20090713
 SEC Charges Four With Fraud   By Shwiff, Kathy, The Wall Street Journal,  Jul 14, 2009  The agency said misleading news releases and Web profiles touting beverages and nutritional supplements pushed the stock price of Seattle-based MitoPharm up more than four times to above $2.30 although MitoPharm's products were in the developmental stage.   
